These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 1355844)
1. Testing for neutralising potential of serum antibodies to tetanus and diphtheria toxin. Sesardic D; Corbel MJ Lancet; 1992 Sep; 340(8821):737-8. PubMed ID: 1355844 [No Abstract] [Full Text] [Related]
2. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. van Gageldonk PG; van Schaijk FG; van der Klis FR; Berbers GA J Immunol Methods; 2008 Jun; 335(1-2):79-89. PubMed ID: 18407287 [TBL] [Abstract][Full Text] [Related]
3. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids. Gupta RK; Siber GR Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950 [TBL] [Abstract][Full Text] [Related]
4. A possible explanation for the discrepancy between ELISA and neutralising antibodies to tetanus toxin. Dokmetjian J; Della Valle C; Lavigne V; de Luján CM; Manghi MA Vaccine; 2000 Jun; 18(24):2698-703. PubMed ID: 10781857 [TBL] [Abstract][Full Text] [Related]
5. Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera. Kristiansen M; Aggerbeck H; Heron I APMIS; 1997 Nov; 105(11):843-53. PubMed ID: 9393555 [TBL] [Abstract][Full Text] [Related]
6. Detoxification of diphtheria and tetanus toxin with formaldehyde. Detection of protein conjugates. Aggerbeck H; Heron I Biologicals; 1992 Jun; 20(2):109-15. PubMed ID: 1389106 [TBL] [Abstract][Full Text] [Related]
7. [Changes of various lipid fractions in experimental intoxication with diphtheric and tetanic toxins]. Rossolini A; Bianchini AM; Mattei C; Marsili C Ann Sclavo; 1975; 17(6):786-98. PubMed ID: 1230058 [TBL] [Abstract][Full Text] [Related]
8. Validation of the combined toxin-binding inhibition test for determination of neutralizing antibodies against tetanus and diphtheria toxins in a vaccine field study in Viet Nam. Hong HA; Ke NT; Nhon TN; Thinh ND; van der Gun JW; Hendriks JT; Kreeftenberg JG Bull World Health Organ; 1996; 74(3):275-82. PubMed ID: 8789926 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of tetanus antitoxin titers of sera from immunized mice and guinea pigs determined by toxin neutralization test and enzyme-linked immunosorbent assay. Gupta RK; Siber GR Biologicals; 1994 Sep; 22(3):215-9. PubMed ID: 7811454 [TBL] [Abstract][Full Text] [Related]
10. Protective monoclonal antibodies to diphtheria toxin. Danelli M das G; Teixeira LM; Formiga LC; Peralta JM Mem Inst Oswaldo Cruz; 1991; 86(2):265-7. PubMed ID: 1842416 [No Abstract] [Full Text] [Related]
11. Consistency of protective antibody levels across lots of intravenous immunoglobulin preparations. Lejtenyi D; Mazer B J Allergy Clin Immunol; 2008 Jan; 121(1):254-5. PubMed ID: 18206511 [No Abstract] [Full Text] [Related]
12. Low seroprevalence of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination. Tanriover MD; Soyler C; Ascioglu S; Cankurtaran M; Unal S Eur J Intern Med; 2014 Jul; 25(6):528-32. PubMed ID: 24814432 [TBL] [Abstract][Full Text] [Related]
13. Expression and purification of a trivalent pertussis toxin-diphtheria toxin-tetanus toxin fusion protein in Escherichia coli. Aminian M; Sivam S; Lee CW; Halperin SA; Lee SF Protein Expr Purif; 2007 Feb; 51(2):170-8. PubMed ID: 16950635 [TBL] [Abstract][Full Text] [Related]
14. [Development of new generation of vaccine against pertussis, cholera, botulism, tetanus, and diphtheria toxins]. Ivanov KK Mol Gen Mikrobiol Virusol; 1993; (2):3-9. PubMed ID: 8515748 [No Abstract] [Full Text] [Related]
15. Pneumococcal Surface Protein A does not affect the immune responses to a combined diphtheria tetanus and pertussis vaccine in mice. Lima FA; Miyaji EN; Quintilio W; Raw I; Ho PL; Oliveira ML Vaccine; 2013 May; 31(20):2465-70. PubMed ID: 23541622 [TBL] [Abstract][Full Text] [Related]
16. Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis. de Voer RM; van der Klis FR; Nooitgedagt JE; Versteegh FG; van Huisseling JC; van Rooijen DM; Sanders EA; Berbers GA Clin Infect Dis; 2009 Jul; 49(1):58-64. PubMed ID: 19480581 [TBL] [Abstract][Full Text] [Related]
17. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines - extended study: correlation of serology with in vivo toxin neutralisation. Sesardic D; Winsnes R; Rigsby P; Behr-Gross ME Pharmeuropa Bio; 2004 Jan; 2003(2):69-76. PubMed ID: 14960263 [TBL] [Abstract][Full Text] [Related]
18. Transcutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless rat. Matsuo K; Ishii Y; Quan YS; Kamiyama F; Mukai Y; Yoshioka Y; Okada N; Nakagawa S J Control Release; 2011 Jan; 149(1):15-20. PubMed ID: 20493218 [TBL] [Abstract][Full Text] [Related]
19. Use of a diluent containing protein for dilution of potent toxins like tetanus toxin for in vivo tests. Gupta RK Biologicals; 1996 Mar; 24(1):75. PubMed ID: 8733604 [No Abstract] [Full Text] [Related]
20. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1. Winsnes R; Sesardic D; Daas A; Behr-Gross ME Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]